A Collection of Patient Samples for Cancer Research
The Alliance NCTN Biorepository and Biospecimen Resource
This effort gathers and stores patient samples from cancer treatment trials to help scientists discover new ways to fight cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11088901 on NIH RePORTER |
What this research studies
This project manages a large collection of high-quality patient samples, like tissues and blood, along with detailed health information, from many years of cancer clinical trials. These samples are carefully collected, processed, and stored to ensure they are useful for future scientific discoveries. By making these valuable samples available to researchers, this resource helps advance our understanding of cancer and develop better treatments. It supports a wide range of studies, including those looking for genetic markers, proteins, and 'liquid biopsies' in the context of therapeutic trials.
Who could benefit from this research
Good fit: Patients who have participated in past or ongoing cancer clinical trials within the Alliance for Clinical Trials in Oncology (Alliance) and the NCTN network are the source of these biospecimens.
Not a fit: Patients not involved in Alliance or NCTN cancer clinical trials, or those not needing cancer treatment, would not directly contribute to or benefit from this specific resource.
Why it matters
Potential benefit: If successful, this resource will accelerate cancer research, leading to the discovery of new biomarkers and more effective treatments for patients.
How similar studies have performed: The concept of biorepositories for collecting and storing patient samples for future research is a well-established and successful approach in medical science.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Watson, Mark a. — Washington University
- Study coordinator: Watson, Mark a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.